Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area others cam kinase ii'

Search results for: 'research area others cam kinase ii'

Items 201-210 of 293

Page
per page
  1. SB 216763
    A8240 SB 216763
     3 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor,ATP-competitive,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL
  2. GSK 650394
    B1051 GSK 650394
     2 Citation
    Target: SGK
    Summary: SGK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.1 mg/mL
  3. Torin 1
    A8312 Torin 1
     7 Citation
    Target: mTOR
    Summary: MTOR inhibitor,potent and selective
  4. 3-Methyladenine
    A8353 3-Methyladenine
     3 Citation
    Target: PI3K
    Summary: Class III PI3K inhibitor
      ≥5 mg/mL
  5. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL
  6. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL
  7. EW-7197
    B5946 EW-7197
     1 Citation
    Target: BMP and Other Activin Receptors
    Summary: Selective inhibitor of TGF-β type I receptor kinase
      ≥39.9 mg/mL
  8. AZD8055
    A8214 AZD8055
     2 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥23.3 mg/mL
  9. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  10. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL

Items 201-210 of 293

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 288item
  2. Peptides 1 item
  3. Peptides & Proteins 1 item
Reversibility
  1. Reversible 26item
  2. Irreversible 7item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 21item
  3. Cathepsins 2item
  4. Histone Deacetylases (HDACs) 5item
  5. Akt 1 item
  6. PI3K 12item
  7. CXCR 2item
  8. Raf 7item
  9. Aurora Kinases 13item
  10. CSF-1R 2item
  11. EZH2 2item
  12. mTOR 6item
  13. Myosin II ATPases 1 item
  14. FLT3 8item
  15. GSK-3 7item
  16. PLK 4item
  17. Chk 5item
  18. Eph Receptors 3item
  19. VEGFR 19item
  20. PDGFR 14item
  21. c-Kit 6item
  22. RET 3item
  23. IRAK 2item
  24. Bromodomain-containing proteins(BRDs) 1 item
  25. p38 6item
  26. PKB 1 item
  27. JNK 2item
  28. SGK 2item
  29. Bcr-Abl 10item
  30. MEK 4item
  31. FGFR 6item
  32. Pim 5item
  33. Voltage-gated Sodium (NaV) Channels 1 item
  34. PP1 1 item
  35. PP2A 1 item
  36. Ribosomal s6 kinases (RSK) 1 item
  37. MET 5item
  38. Src 8item
  39. Trk Receptors 3item
  40. EGFR 10item
  41. ROCK 6item
  42. BTK 1 item
  43. PAK 3item
  44. FAK 4item
  45. BMP and Other Activin Receptors 2item
  46. JAK 8item
  47. Syk 5item
  48. DNA-PK 3item
  49. AMPK 2item
  50. PDHK 1 item
  51. Angiotensin AT2 Receptors 3item
  52. CFTR 4item
  53. Topoisomerases 7item
  54. Renin 1 item
  55. HIV proteases 1 item
  56. Pepsins 1 item
  57. ErbB 2item
  58. S6 kinases 1 item
  59. Toll-like receptors (TLRs) 1 item
  60. Adenosine Kinases 2item
  61. ERK 3item
  62. c-MET 5item
  63. PKC 5item
  64. Calpains 1 item
  65. Ubiquitin-specific proteases 1 item
  66. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  67. Lyn 1 item
  68. SGLT 1 item
  69. HER2 2item
  70. Pyk2 3item
  71. USP 1 item
  72. 5-HT2 Receptors 1 item
  73. LRRK2 3item
  74. Insulin and Insulin-like Receptors 2item
  75. ALK 3item
  76. ROS1 1 item
  77. Sphingosine kinases (SphKs) 2item
  78. GTPases 1 item
  79. PKG 1 item
  80. PKA 1 item
  81. Myosin light chain kinases (MLCKs) 2item
  82. D1 and D5 Receptors 1 item
  83. D2 Receptors 1 item
  84. D3 Receptors 1 item
  85. 5-HT1 Receptors 1 item
  86. 5-HT7 Receptors 1 item
  87. CaM-KK 1 item
  88. MELK 1 item
  89. Insulin-like growth factors (IGFs) 1 item
  90. Clk 1 item
  91. NUAK1 1 item
  92. NUAK2 1 item
  93. MK2 2item
  94. Fatty-acid-binding proteins (FABPs) 1 item
  95. Tie-2 2item
  96. RSK 1 item
  97. ATM/ATR 3item
  98. YAP 1 item
  99. CK1 1 item
  100. Histamine H4 Receptors 1 item
  101. Farnesyl Diphosphate Synthases 1 item
  102. CK2 3item
  103. HIPK2 1 item
  104. HIPK3 1 item
  105. HIV Integrases 1 item
  106. Squalene epoxidases 1 item
  107. 20S proteasomal chymotrypsin 1 item
  108. Geranylgeranyltransferase I 1 item
  109. Farnesyltransferase 1 item
  110. P2X Receptors 1 item
  111. Carbonic Anhydrases 1 item
  112. Synthases/Synthetases 1 item
  113. c-Fyn 1 item
  114. TAK1 1 item
  115. P110 1 item
  116. Hck 1 item
  117. Insulin Receptors 1 item
  118. IRG-1R 1 item
  119. Cdc2-like kinase (Clk) 1 item
  120. eEF-2 1 item
  121. Cdc7 1 item
  122. ZAP-70 1 item
  123. Angiotensin AT1 Receptors 2item
  124. ATGL 1 item
  125. PP4 1 item
  126. c-RET 1 item
  127. p70 rsk 1 item
  128. TAM kinase 1 item
  129. AXL 1 item
  130. Dipeptidyl-peptidase II 1 item
  131. c-Fms tyrosine kinase 1 item
  132. PAR 1 item
  133. human lyase 1 item
  134. STK 1 item
  135. MSK 1 item
  136. HCV polymerase 1 item
  137. Lyn kinase 1 item
  138. Elastases 1 item
  139. ITK 1 item
  140. NUAK 1 item
  141. DCLK2 1 item
  142. Lck 1 item
  143. PKD 1 item
  144. tropomyosin receptor kinase 1 item
  145. SK 1 item
  146. ATM 1 item
  147. PIKfyve 1 item
  148. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 253item
  2. Cell Experiments 162item
Related Disease
  1. Acute Lung Injury 1 item
  2. Acute Myelogenous Leukemia 2item
  3. Acute Myeloid Leukemia 16item
  4. Adrenocortical Carcinoma 2item
  5. Advanced Renal Cell Carcinoma 1 item
  6. Bladder Cancer 5item
  7. Bladder Carcinoma 1 item
  8. B-lymphoid Malignancies 1 item
  9. Breast Cancer 46item
  10. Cancer 172item
  11. Cervical Cancer 4item
  12. Cholangiocarcinoma 2item
  13. Chronic Lymphocytic Leukemia 2item
  14. Clear Cell Renal Cell Carcinoma 1 item
  15. Colon Cancer 20item
  16. Colon Carcinoma 2item
  17. Colorectal Cancer 21item
  18. Diabetes 2item
  19. Dyslipidemia 1 item
  20. Glioblastoma 16item
  21. Glioma 6item
  22. Hepatitis C 1 item
  23. Hepatocellular Carcinoma 4item
  24. HIV Infections 1 item
  25. Immunological Diseases 1 item
  26. Inflammatory Bowel Disease 1 item
  27. Inflammatory Diseases 6item
  28. Leukemia 10item
  29. Liver Cancer 4item
  30. Lung Cancer 18item
  31. Lung Carcinoma 3item
  32. Lymphoma 12item
  33. Mantle Cell Lymphoma 1 item
  34. Melanoma 14item
  35. Multiple Myeloma 7item
  36. Myelofibrosis 1 item
  37. Myeloma 1 item
  38. Neuroblastoma 3item
  39. Non-small Cell Lung Cancer 5item
  40. Non-small Cell Lung Carcinoma 1 item
  41. Ovarian Cancer 18item
  42. Pancreatic Cancer 24item
  43. Prostate Cancer 20item
  44. Psoriasis 1 item
  45. Pulmonary Arterial Hypertension 1 item
  46. Renal Cancer 3item
  47. Renal Cell Carcinoma 6item
  48. Rheumatoid Arthritis 5item
  49. Schizophrenia 1 item
  50. Testicular Cancer 1 item
  51. Thyroid Cancer 5item
  52. Type 2 Diabetes 4item